Anti-inflammatory agent 107 is an orally effective compound that serves as a potent anti-inflammatory agent. It inhibits NF-kappaB with a strong binding affinity of -9.4578 kcal/mol. The agent reduces levels of inflammatory markers such as TNF-alpha, IL-6, INF-gamma, NF-kappabeta, CRP (C-reactive protein), and ESR (Erythrocyte Sedimentation Rate). Additionally, it enhances the activity of endogenous antioxidant systems by increasing SOD (superoxide dismutase), CAT (catalase), and GSH (glutathione). Notably, Anti-inflammatory agent 107 exhibits no hepatic or renal toxicity and provides significant protective effects for the liver and kidneys. It also improves leukocyte infiltration and tissue edema in a dose-dependent manner, making it valuable for anti-inflammatory research.
